Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Journal of Internal Medicine|March 31, 2004
Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseasesA Mavri, M-C Alessi, I Juhan-Vague
Annals of Medicine|August 1, 1996
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitusI Juhan-Vague, M C Alessi, P Vague
Diabetologia|July 1, 1991
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisI Juhan-Vague, M C Alessi, P Vague
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Relations between hemostatic variables, insulin resistance and inflammationPierre E Morange, M C Alessi, I Juhan-Vague
Annales De Biologie Clinique|January 1, 1987
[Anti-activator inhibitors of plasminogen]I Juhan-Vague, M C Alessi, M F Aillaud
Annals of Medicine|February 24, 2001
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesityI Juhan-Vague, M C Alessi, P E Morange
Bailliere'S Clinical Haematology|June 1, 1995
Pathophysiology of fibrinolysisI Juhan-Vague, M C Alessi, P J Declerck
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 2, 2003
Statins: maid-of-all-work in cardiovascular diseases!G Nalbone, D Bernot, F Peiretti, et al.
Thrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.
Journal of Thrombosis and Haemostasis : JTH|December 18, 2009
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic controlB Gaborit, C Frère, T Cuisset, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Journal of Internal Medicine|March 31, 2004
Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseasesA Mavri, M-C Alessi, I Juhan-Vague
Annals of Medicine|August 1, 1996
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitusI Juhan-Vague, M C Alessi, P Vague
Diabetologia|July 1, 1991
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisI Juhan-Vague, M C Alessi, P Vague
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Relations between hemostatic variables, insulin resistance and inflammationPierre E Morange, M C Alessi, I Juhan-Vague
Annales De Biologie Clinique|January 1, 1987
[Anti-activator inhibitors of plasminogen]I Juhan-Vague, M C Alessi, M F Aillaud
Annals of Medicine|February 24, 2001
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesityI Juhan-Vague, M C Alessi, P E Morange
Bailliere'S Clinical Haematology|June 1, 1995
Pathophysiology of fibrinolysisI Juhan-Vague, M C Alessi, P J Declerck
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 2, 2003
Statins: maid-of-all-work in cardiovascular diseases!G Nalbone, D Bernot, F Peiretti, et al.
Thrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.
Journal of Thrombosis and Haemostasis : JTH|December 18, 2009
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic controlB Gaborit, C Frère, T Cuisset, et al.
Pageof 15